Pyoderma Gangrenosum as the Initial Presentation of Ulcerative Colitis: A Case Report
PDF (Español (España))
Word (temporal) (Español (España))
سرور مجازی ایران Decentralized Exchange

How to Cite

1.
López Sáenz JG, Vargas Navarro F. Pyoderma Gangrenosum as the Initial Presentation of Ulcerative Colitis: A Case Report . Rev.méd.sinerg. [Internet]. 2024Jan.1 [cited 2024Dec.21];9(1):e1126. Available from: https://revistamedicasinergia.com/index.php/rms/article/view/1126

Abstract

Pyoderma gangrenosum could be, in some cases, the most visible manifestation of a systemic disease. Once histological confirmation of pyoderma gangrenosum by biopsy is made and other causes of skin lesions had been excluded, it is important to conduct a comprehensive diagnostic workup to determine if the lesion is associated with a systemic disease. In the context of this patient, it was determined that these skin lesions were associated with inflammatory bowel disease that had not been previously documented. The treatment of these two pathologies goes hand in hand, so is relevant to determine the characteristics of each patient in order to achieve appropriate therapeutic interventions.

https://doi.org/10.31434/rms.v9i1.1126

Keywords

inflammatory bowel diseases. ulcerative colitis. pyoderma gangrenosum. skin diseases.
PDF (Español (España))
Word (temporal) (Español (España))

References

Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet [Internet]. 2017 (citado 15 noviembre 2023);389(10080):1756-1770. DOI: 10.1016/S0140-6736(16)32126-2

Gros B, Kaplan GG. Ulcerative Colitis in Adults: A Review. JAMA [Internet]. 12 septiembre 2023 (citado 15 noviembre 2023);330(10):951-965. DOI: 10.1001/jama.2023.15389

Weizman AV, Huang B, Targan S, et al. Pyoderma gangrenosum among patients with inflammatory bowel disease: a descriptive cohort study. J Cutan Med Surg. [Internet]. 2015 (citado 15 noviembre 2023);19(2):125-131. DOI: 10.2310/7750.2014.14053

Plumptre I, Knabel D, Tomecki K. Pyoderma Gangrenosum: A Review for the Gastroenterologist. Inflamm Bowel Dis. [Internet]. 2018 (citado 15 noviembre 2023);24(12):2510-2517. DOI: 10.1093/ibd/izy174

Figueras Nart I, Martín-Sala S, Álvarez-Abella A, Jucglà Serra A. Pioderma gangrenoso. Piel [Internet]. 2012 (citado 15 noviembre 2023);27(3):132–144. DOI: 10.1016/j.piel.2011.10.012

Ford AC, Moayyedi P, Hanauer SB. Ulcerative colitis. BMJ [Internet]. 2013 (citado 15 noviembre 2023);346:f432. DOI:10.1136/bmj.f432

Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet [Internet]. 2012 (citado 15 noviembre 2023);380(9853):1606-19. DOI: 10.1016/S0140-6736(12)60150

Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol [Internet]. Marzo 2019 (citado 15 noviembre 2023);114(3):384-413. DOI: 10.14309/ajg.0000000000000152

Kucharzik T, Koletzko S, Kannengiesser K, Dignass A. Ulcerative Colitis-Diagnostic and Therapeutic Algorithms. Dtsch Arztebl Int. [Internet]. 17 agosto 2020 (citado 15 noviembre 2023);117(33-34):564-574. DOI: 10.3238/arztebl.2020.0564

Ferretti F, Cannatelli R, Monico MC, Maconi G, Ardizzone S. An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis. J Clin Med. [Internet]. 20 abril 2022 (citado 15 noviembre 2023);11(9):2302. DOI: 10.3390/jcm11092302

Wollina U. Pyoderma gangrenosum--a review. Orphanet J Rare Dis. [Internet]. 2007 (citado 15 noviembre 2023);2:19. DOI: 10.1186/1750-1172-2-19

Ahn C, Negus D, Huang W. Pyoderma gangrenosum: a review of pathogenesis and treatment. Expert Rev Clin Immunol. [Internet]. 2018 (citado 15 noviembre 2023);14(3):225-233. DOI: 10.1080/1744666X.2018.1438269

Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol. [Internet]. 2012 (citado 15 noviembre 2023);13(3):191-211. DOI: 10.2165/11595240-000000000-00000

George C, Deroide F, Rustin M. Pyoderma gangrenosum – a guide to diagnosis and management. Clin Med (Lond) [Internet]. 2019 (citado 15 noviembre 2023); 19(3): 224–228. DOI: 10.7861/clinmedicine.19-3-224

Flora A, Kozera E, Frew JW. Pyoderma gangrenosum: A systematic review of the molecular characteristics of disease. Exp Dermatol. [Internet]. Abril 2022 (citado 15 noviembre 2023);31(4):498-515. DOI: 10.1111/exd.14534

Rodríguez-Zúñiga MJM, Heath MS, Gontijo JRV, Ortega-Loayza AG. Pyoderma gangrenosum: a review with special emphasis on Latin America literature. An Bras Dermatol. [Internet]. Nov-Dic 2019 (citado 15 noviembre 2023);94(6):729-743. DOI: 10.1016/j.abd.2019.06.001

Maverakis E, Ma C, Shinkai K, Fiorentino D, Callen JP, Wollina U, Marzano AV, Wallach D, Kim K, Schadt C, Ormerod A, Fung MA, Steel A, Patel F, Qin R, Craig F, Williams HC, Powell F, Merleev A, Cheng MY. Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts. JAMA Dermatol. [Internet]. 01 abril 2018 (citado 15 noviembre 2023);154(4):461-466. DOI: 10.1001/jamadermatol.2017.5980

Alavi A, French L, Davis M, Brassard A, Kirsner R. Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment. Am J Clin Dermatol. [Internet]. 2017 (citado 15 noviembre 2023);18:355–372. DOI: 10.1007/s40257-017-0251-7

Chen B, Li W, Qu B. Practical aspects of the diagnosis and management of pyoderma gangrenosum. Front Med (Lausanne) [Internet]. 14 febrero 2023 (citado 15 noviembre 2023);10:1134939. DOI: 10.3389/fmed.2023.1134939

Dissemond J, Marzano AV, Hampton PJ, Ortega-Loayza AG. Pyoderma Gangrenosum: Treatment Options. Drugs [Internet]. Septiembre 2023 (citado 15 noviembre 2023);83(14):1255-1267. DOI: 10.1007/s40265-023-01931-3

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2023 Array

Downloads

Download data is not yet available.
فروشگاه اینترنتی vpn for android خرید vpn سایت شرط بندی